SlideShare a Scribd company logo
1 of 2
Download to read offline
Chemistry,
Manufacturing
and Controls
The chemistry, manufacturing and controls (CMC) experts at Cardinal
Health Specialty Solutions provide consulting services that yield
efficient regulatory approaches to pharmaceutical, biologic and
medical device development. We partner with you to develop your
regulatory strategy, as well as author, prepare, review and submit
CMC documentation for all phases of development. Our CMC
experts have experience with complete analytical and formulation
development programs, from initial development to production of
clinical and commercial supplies for small and large molecules.
The diverse expertise of our CMC team includes:
•	 Small molecules (℞ and over-the-counter [OTC] products)
•	 Biologic products (including monoclonal antibodies, proteins, oligonucleotides,
synthetic peptides, cell- and tissue-based products, stem-cell-based products,
vaccines, gene therapy and blood and blood-derived products)
•	 New chemical entity, generic and biosimilar development
•	 Human and veterinary product development
•	 Medical devices and drug/device combination products
•	 Products in all major dosage forms
Cardinal Health
Specialty Solutions
cardinalhealth.com
© 2016 Cardinal Health. All Rights Reserved. CARDINAL HEALTH, the Cardinal Health LOGO and ESSENTIAL TO CARE
are trademarks or registered trademarks of Cardinal Health. All other marks are the property of their respective owners.
Lit. No. 1SR16-482303 (04/2016)
Our solutions
Regulatory •	 Development of global regulatory strategies for synthetic and biologic products
•	 Development, preparation and maintenance of global regulatory submissions
(including Module 2 QOS, Module 3 and labeling)
•	 Preparation and maintenance of Drug Master Files
•	 Guidance with FDA and global regulatory health authority requirements, regulations and guidances
•	 Interactions with FDA and global regulatory health authorities, including information requests
and meetings (eg, pre-IND, end-of-phase 2, pre-NDA and pre-BLA)
•	 Support for pre-approval inspections of manufacturing facilities
•	 Development and maintenance of post-approval documentation (eg, annual reports,
Post-Approval Supplements (PASs), Changes Being Effected (CBE) and Type I and II variations)
•	 Management of active pharmaceutical ingredient (API) and drug product development programs
•	 Due diligence reviews and gap analyses of development programs, marketing applications and
manufacturing sites
•	 Guidance on API process development and optimization
•	 Guidance on biologic drug substance development and manufacturing
•	 Formulation development for small and large molecules
•	 Analytical method development and validation for small and large molecules
•	 Management of clinical trial material production
•	 Support for manufacturing process validation
•	 Development of quality assurance programs, including quality systems and standard operating procedures
Pharmaceutical and
biopharmaceutical
development
For more information about our
chemistry, manufacturing and controls services, visit us at
cardinalhealth.com/regulatorysciences or call us at 913.451.3955.
How our solutions help
Our CMC experts help you ensure that your final drug product meets the regulatory
compliance and quality standards of FDA and global health authorities at each clinical
phase and commercial launch. We have a track record of successful interactions with
regulatory authorities worldwide and nearly four decades of experience in scientific
and regulatory consulting and regulatory submission operations.

More Related Content

What's hot

Bilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory OveriewBilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory OveriewBilcare GCS
 
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRama Shukla
 
Food Regulatory Affairs Program
Food Regulatory Affairs ProgramFood Regulatory Affairs Program
Food Regulatory Affairs ProgramAnjali Gupta
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory AffairsNamdeo Shinde
 
Food Safety Modernization Act (FSMA) regulatory requirements by FDA
Food Safety Modernization Act (FSMA) regulatory requirements by FDAFood Safety Modernization Act (FSMA) regulatory requirements by FDA
Food Safety Modernization Act (FSMA) regulatory requirements by FDABrian Thomas
 
Are you ready to implement FDA Food Safety Modernization Act?
 Are you ready to implement FDA Food Safety Modernization Act? Are you ready to implement FDA Food Safety Modernization Act?
Are you ready to implement FDA Food Safety Modernization Act?Nikoo Arasteh
 
Regulatory affairs.
Regulatory affairs.Regulatory affairs.
Regulatory affairs.Naila Kanwal
 
Accelerated approval drugs - 9 approaches for managing regulatory approval an...
Accelerated approval drugs - 9 approaches for managing regulatory approval an...Accelerated approval drugs - 9 approaches for managing regulatory approval an...
Accelerated approval drugs - 9 approaches for managing regulatory approval an...Ben Bradley
 
Regulatory Reform - Are we heading in the right direction?
Regulatory Reform - Are we heading in the right direction?Regulatory Reform - Are we heading in the right direction?
Regulatory Reform - Are we heading in the right direction?TGA Australia
 
Therapeutic Innovation Australia Symposium 2017 - SME Assist
Therapeutic Innovation Australia Symposium 2017 - SME AssistTherapeutic Innovation Australia Symposium 2017 - SME Assist
Therapeutic Innovation Australia Symposium 2017 - SME AssistTGA Australia
 
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4Bringing Legacy Combination Products into Compliance with 21 CFR Part 4
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4Peter Dellva
 
TGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updatesTGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updatesTGA Australia
 
Drug regulatory affairs - 1
Drug regulatory affairs - 1Drug regulatory affairs - 1
Drug regulatory affairs - 1Tanuja Bisht
 
Design and Implementation for HARPC
Design and Implementation for HARPCDesign and Implementation for HARPC
Design and Implementation for HARPCAudioEducator
 
FSMA Impacts Packaging
FSMA Impacts PackagingFSMA Impacts Packaging
FSMA Impacts PackagingKerry Beach
 
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...Peter Dellva
 
Writing Your Food Safety Plan- NICRA
Writing Your Food Safety Plan- NICRA Writing Your Food Safety Plan- NICRA
Writing Your Food Safety Plan- NICRA Katie Worley
 
Best Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging LinesBest Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging LinesManish Bhatkar
 
5 Critical Areas of Combination Drug Compliance
5 Critical Areas of Combination Drug Compliance5 Critical Areas of Combination Drug Compliance
5 Critical Areas of Combination Drug CompliancePeter Dellva
 

What's hot (20)

Bilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory OveriewBilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory Overiew
 
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
 
Food Regulatory Affairs Program
Food Regulatory Affairs ProgramFood Regulatory Affairs Program
Food Regulatory Affairs Program
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
Food Safety Modernization Act (FSMA) regulatory requirements by FDA
Food Safety Modernization Act (FSMA) regulatory requirements by FDAFood Safety Modernization Act (FSMA) regulatory requirements by FDA
Food Safety Modernization Act (FSMA) regulatory requirements by FDA
 
Are you ready to implement FDA Food Safety Modernization Act?
 Are you ready to implement FDA Food Safety Modernization Act? Are you ready to implement FDA Food Safety Modernization Act?
Are you ready to implement FDA Food Safety Modernization Act?
 
Regulatory affairs.
Regulatory affairs.Regulatory affairs.
Regulatory affairs.
 
Regulatory Affairs
Regulatory AffairsRegulatory Affairs
Regulatory Affairs
 
Accelerated approval drugs - 9 approaches for managing regulatory approval an...
Accelerated approval drugs - 9 approaches for managing regulatory approval an...Accelerated approval drugs - 9 approaches for managing regulatory approval an...
Accelerated approval drugs - 9 approaches for managing regulatory approval an...
 
Regulatory Reform - Are we heading in the right direction?
Regulatory Reform - Are we heading in the right direction?Regulatory Reform - Are we heading in the right direction?
Regulatory Reform - Are we heading in the right direction?
 
Therapeutic Innovation Australia Symposium 2017 - SME Assist
Therapeutic Innovation Australia Symposium 2017 - SME AssistTherapeutic Innovation Australia Symposium 2017 - SME Assist
Therapeutic Innovation Australia Symposium 2017 - SME Assist
 
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4Bringing Legacy Combination Products into Compliance with 21 CFR Part 4
Bringing Legacy Combination Products into Compliance with 21 CFR Part 4
 
TGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updatesTGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updates
 
Drug regulatory affairs - 1
Drug regulatory affairs - 1Drug regulatory affairs - 1
Drug regulatory affairs - 1
 
Design and Implementation for HARPC
Design and Implementation for HARPCDesign and Implementation for HARPC
Design and Implementation for HARPC
 
FSMA Impacts Packaging
FSMA Impacts PackagingFSMA Impacts Packaging
FSMA Impacts Packaging
 
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...
 
Writing Your Food Safety Plan- NICRA
Writing Your Food Safety Plan- NICRA Writing Your Food Safety Plan- NICRA
Writing Your Food Safety Plan- NICRA
 
Best Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging LinesBest Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging Lines
 
5 Critical Areas of Combination Drug Compliance
5 Critical Areas of Combination Drug Compliance5 Critical Areas of Combination Drug Compliance
5 Critical Areas of Combination Drug Compliance
 

Similar to CMC Experts Guide Pharma Development

Regulatory affairs by sachin gundecha
Regulatory affairs by sachin gundechaRegulatory affairs by sachin gundecha
Regulatory affairs by sachin gundechaSachin Gundecha
 
Product type- Drug development - Departments of facility- Registration pathwa...
Product type- Drug development - Departments of facility- Registration pathwa...Product type- Drug development - Departments of facility- Registration pathwa...
Product type- Drug development - Departments of facility- Registration pathwa...Asmaa Khalil
 
OC Partnership Presentation2016
OC Partnership Presentation2016OC Partnership Presentation2016
OC Partnership Presentation2016Bill McGuane
 
1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptxMdJubair13
 
3716_A5_Capabilities_Brochure_R7
3716_A5_Capabilities_Brochure_R73716_A5_Capabilities_Brochure_R7
3716_A5_Capabilities_Brochure_R7Catharine S
 
(CORP02)_inVentiv_Health_Clinical_Overview_Brochure
(CORP02)_inVentiv_Health_Clinical_Overview_Brochure(CORP02)_inVentiv_Health_Clinical_Overview_Brochure
(CORP02)_inVentiv_Health_Clinical_Overview_BrochureJane Hibberd
 
MMStan-Brochure for Clients
MMStan-Brochure for ClientsMMStan-Brochure for Clients
MMStan-Brochure for ClientsMathew George
 
Clinical Research Organization Services | Contract Research Company - Pepgra
Clinical Research Organization Services | Contract Research Company - PepgraClinical Research Organization Services | Contract Research Company - Pepgra
Clinical Research Organization Services | Contract Research Company - PepgraPEPGRA Healthcare
 
CHRS Animal Health Brochure
CHRS Animal Health BrochureCHRS Animal Health Brochure
CHRS Animal Health BrochureBruce Copeland
 
Updated capabilities overview1
Updated  capabilities overview1Updated  capabilities overview1
Updated capabilities overview1malbergo
 
The pharmaceutical manufacturing principles - Quality Control
The pharmaceutical manufacturing principles - Quality ControlThe pharmaceutical manufacturing principles - Quality Control
The pharmaceutical manufacturing principles - Quality ControlInbarajAnandan
 
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdfsureshsamineni1
 
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...yashdhewal
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCovance
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCovance
 
Kineticos Life Sciences Management Consulting
Kineticos Life Sciences Management ConsultingKineticos Life Sciences Management Consulting
Kineticos Life Sciences Management ConsultingGlen Martin
 
Kineticos Life Sciences Management Consulting Capabilities 2016
Kineticos Life Sciences Management Consulting Capabilities 2016Kineticos Life Sciences Management Consulting Capabilities 2016
Kineticos Life Sciences Management Consulting Capabilities 2016Glen Martin
 

Similar to CMC Experts Guide Pharma Development (20)

Regulatory affairs by sachin gundecha
Regulatory affairs by sachin gundechaRegulatory affairs by sachin gundecha
Regulatory affairs by sachin gundecha
 
Product type- Drug development - Departments of facility- Registration pathwa...
Product type- Drug development - Departments of facility- Registration pathwa...Product type- Drug development - Departments of facility- Registration pathwa...
Product type- Drug development - Departments of facility- Registration pathwa...
 
OC Partnership Presentation2016
OC Partnership Presentation2016OC Partnership Presentation2016
OC Partnership Presentation2016
 
1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx
 
3716_A5_Capabilities_Brochure_R7
3716_A5_Capabilities_Brochure_R73716_A5_Capabilities_Brochure_R7
3716_A5_Capabilities_Brochure_R7
 
(CORP02)_inVentiv_Health_Clinical_Overview_Brochure
(CORP02)_inVentiv_Health_Clinical_Overview_Brochure(CORP02)_inVentiv_Health_Clinical_Overview_Brochure
(CORP02)_inVentiv_Health_Clinical_Overview_Brochure
 
Resume 03-31-2015
Resume 03-31-2015Resume 03-31-2015
Resume 03-31-2015
 
MMStan-Brochure for Clients
MMStan-Brochure for ClientsMMStan-Brochure for Clients
MMStan-Brochure for Clients
 
Clinical Research Organization Services | Contract Research Company - Pepgra
Clinical Research Organization Services | Contract Research Company - PepgraClinical Research Organization Services | Contract Research Company - Pepgra
Clinical Research Organization Services | Contract Research Company - Pepgra
 
CHRS Animal Health Brochure
CHRS Animal Health BrochureCHRS Animal Health Brochure
CHRS Animal Health Brochure
 
Updated capabilities overview1
Updated  capabilities overview1Updated  capabilities overview1
Updated capabilities overview1
 
The pharmaceutical manufacturing principles - Quality Control
The pharmaceutical manufacturing principles - Quality ControlThe pharmaceutical manufacturing principles - Quality Control
The pharmaceutical manufacturing principles - Quality Control
 
James Profile
James ProfileJames Profile
James Profile
 
jos cv quality July 2016
jos cv quality July 2016jos cv quality July 2016
jos cv quality July 2016
 
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
 
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
 
Kineticos Life Sciences Management Consulting
Kineticos Life Sciences Management ConsultingKineticos Life Sciences Management Consulting
Kineticos Life Sciences Management Consulting
 
Kineticos Life Sciences Management Consulting Capabilities 2016
Kineticos Life Sciences Management Consulting Capabilities 2016Kineticos Life Sciences Management Consulting Capabilities 2016
Kineticos Life Sciences Management Consulting Capabilities 2016
 

CMC Experts Guide Pharma Development

  • 1. Chemistry, Manufacturing and Controls The chemistry, manufacturing and controls (CMC) experts at Cardinal Health Specialty Solutions provide consulting services that yield efficient regulatory approaches to pharmaceutical, biologic and medical device development. We partner with you to develop your regulatory strategy, as well as author, prepare, review and submit CMC documentation for all phases of development. Our CMC experts have experience with complete analytical and formulation development programs, from initial development to production of clinical and commercial supplies for small and large molecules. The diverse expertise of our CMC team includes: • Small molecules (℞ and over-the-counter [OTC] products) • Biologic products (including monoclonal antibodies, proteins, oligonucleotides, synthetic peptides, cell- and tissue-based products, stem-cell-based products, vaccines, gene therapy and blood and blood-derived products) • New chemical entity, generic and biosimilar development • Human and veterinary product development • Medical devices and drug/device combination products • Products in all major dosage forms Cardinal Health Specialty Solutions
  • 2. cardinalhealth.com © 2016 Cardinal Health. All Rights Reserved. CARDINAL HEALTH, the Cardinal Health LOGO and ESSENTIAL TO CARE are trademarks or registered trademarks of Cardinal Health. All other marks are the property of their respective owners. Lit. No. 1SR16-482303 (04/2016) Our solutions Regulatory • Development of global regulatory strategies for synthetic and biologic products • Development, preparation and maintenance of global regulatory submissions (including Module 2 QOS, Module 3 and labeling) • Preparation and maintenance of Drug Master Files • Guidance with FDA and global regulatory health authority requirements, regulations and guidances • Interactions with FDA and global regulatory health authorities, including information requests and meetings (eg, pre-IND, end-of-phase 2, pre-NDA and pre-BLA) • Support for pre-approval inspections of manufacturing facilities • Development and maintenance of post-approval documentation (eg, annual reports, Post-Approval Supplements (PASs), Changes Being Effected (CBE) and Type I and II variations) • Management of active pharmaceutical ingredient (API) and drug product development programs • Due diligence reviews and gap analyses of development programs, marketing applications and manufacturing sites • Guidance on API process development and optimization • Guidance on biologic drug substance development and manufacturing • Formulation development for small and large molecules • Analytical method development and validation for small and large molecules • Management of clinical trial material production • Support for manufacturing process validation • Development of quality assurance programs, including quality systems and standard operating procedures Pharmaceutical and biopharmaceutical development For more information about our chemistry, manufacturing and controls services, visit us at cardinalhealth.com/regulatorysciences or call us at 913.451.3955. How our solutions help Our CMC experts help you ensure that your final drug product meets the regulatory compliance and quality standards of FDA and global health authorities at each clinical phase and commercial launch. We have a track record of successful interactions with regulatory authorities worldwide and nearly four decades of experience in scientific and regulatory consulting and regulatory submission operations.